What are peptides, actually?
Your body is a peptide factory. Right now, as you read this, it's making thousands of different peptides — short chains of amino acids that act as signals. Insulin is a peptide. Oxytocin is a peptide. The thing that makes you feel full after a meal? Also a peptide.
A peptide is basically a tiny protein. Proteins are long chains of amino acids folded into complex shapes. Peptides are the shorter chains — usually anywhere from 2 to about 50 amino acids long. Beyond that, scientists start calling them proteins.
When people talk about "taking peptides," they usually mean one of two things:
FDA-approved peptide drugs. These have been through clinical trials and are prescribed like any other medication. Semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide are peptides. So is insulin. So are a handful of others you've probably never heard of, used for everything from osteoporosis to hereditary angioedema.
Compounded or research peptides. These are peptides that exist in scientific literature — sometimes with significant evidence, sometimes barely any — but haven't gone through full FDA approval for most of their rumored uses. BPC-157, TB-500, ipamorelin, and most of what biohackers talk about on X live here.
That second category is where most of the conversation (and most of the confusion) happens.
Peptides vs. steroids — what's the actual difference?
This is one of the most Googled questions in the space, and the answer matters because the two categories get mentally lumped together even though they work completely differently.
Steroids (specifically anabolic androgenic steroids like testosterone, trenbolone, nandrolone) are synthetic versions of testosterone. They bind to androgen receptors throughout the body and drive muscle growth, strength, aggression, and a long list of side effects. They're powerful, well-studied, and come with predictable trade-offs: suppressed natural testosterone production, cardiovascular strain, liver stress depending on the form, and hormonal disruption that can last months or longer after you stop.
Peptides don't bind to androgen receptors and don't act like testosterone. Each peptide has its own specific target — a specific receptor, a specific enzyme, a specific signaling pathway. BPC-157 doesn't do what TB-500 does, which doesn't do what semaglutide does.
Some peptides (like growth-hormone-releasing peptides) can indirectly affect hormones, but the mechanism is fundamentally different from steroids. Most peptides people talk about for recovery, cognition, or longevity don't touch the androgen system at all.
Practical difference: steroids are a sledgehammer that hits everything. Most peptides are supposed to be a precision tool that hits one thing. Whether any given peptide actually is that precise is a different question — which is what the "Evidence" section on each Kalios compound page tries to answer.
The legal landscape — why this gets confusing fast
Here's the part that trips everyone up. When you hear a peptide described as "not FDA-approved," that doesn't automatically mean illegal. It could mean any of four very different things:
1. FDA-approved drugs. Semaglutide, tirzepatide, testosterone, insulin, and a few others. You get these with a prescription from your doctor, filled at a regular pharmacy. Clear legal status. Known quality standards.
2. Compounded drugs (503A pharmacies). Licensed compounding pharmacies can legally make custom-formulated medications for individual patients with a prescription. For peptides, this is how most people access things like BPC-157, ipamorelin, or sermorelin — through a telehealth clinic that writes a prescription, which a 503A pharmacy fills.
The catch: a peptide has to be either (a) part of an FDA-approved drug, (b) covered by a USP monograph, or (c) on the FDA's 503A Bulks List. In 2023, FDA moved a lot of peptides to "Category 2," effectively blocking compounding. In 2026, that's being reviewed — see the FDA PCAC 2026 tracker for the current state of that review.
3. 503B outsourcing facilities. Larger-scale compounding facilities that can make batches of compounded medications for clinics. Same legal framework as 503A but at scale. More relevant to clinic operations than individual patients.
4. Research chemicals. Peptides sold with "for research use only, not for human consumption" labels. These are in a legal gray zone — technically legal to sell for research purposes, technically not intended for humans, practically bought and used by people anyway. Quality control is the buyer's problem. Purity varies wildly between vendors. No prescription. No pharmacy. No medical oversight.
Most of the compounds on Kalios fall into categories 2 or 4 depending on the specific peptide and the current regulatory state. The compound pages try to name which bucket each one is in.
How people actually use peptides
Most therapeutic peptides are taken by injection — specifically subcutaneous injection, which means into the fat layer just under the skin (similar to how insulin is administered). A few are taken orally, sublingually (under the tongue), or intranasally. Very few are absorbed well by mouth because stomach acid breaks them down, which is why injection is the default.
A few concepts that show up constantly:
Reconstitution. Many peptides ship as a freeze-dried powder in a small glass vial. You mix it with bacteriostatic water (a sterile water with a small amount of preservative) before use. The ratio of water to peptide determines how concentrated each dose is, which then determines how many units on an insulin syringe equals your intended milligram dose. This is why there's a dosing calculator on Kalios — the math is annoying and easy to get wrong.
Cycling. The practice of using a peptide for a defined period (commonly 4–12 weeks) and then stopping for a similar period. The logic is usually one of two things: preventing tolerance/receptor downregulation, or limiting exposure to a compound with unknown long-term effects. Whether cycling is actually necessary for any given peptide is usually more theoretical than proven.
Stacks. Using multiple peptides together. Sometimes for complementary effects (a recovery peptide plus a growth hormone peptide), sometimes just because biohacker culture leans that way. Stack choices are usually anecdotal — there's rarely clinical evidence for specific combinations.
Storage. Reconstituted peptides typically need refrigeration and last somewhere between 2 weeks and a few months depending on the compound. Freeze-dried powder is far more stable — sometimes years if kept cold and dry. Each compound page on Kalios covers the specifics.
None of this is an instruction manual. It's context so that when a compound page mentions "reconstitute with 2mL BAC water and dose 250mcg twice daily," you know what those words mean.
The honest risk picture
If you only read one section, read this one.
Quality is the biggest practical risk. A peptide that arrives from a gray-market vendor might be the right compound at the right purity, might be underdosed, might be a completely different compound, or might be contaminated with something that shouldn't be in an injection. Third-party lab testing (HPLC + mass spec) from a recent batch is the minimum bar. Many vendors don't provide this. Prices vary 2–3× between sources and lower often correlates with lower quality, not a bargain.
The unknown-long-term problem. Most research peptides have never been studied in humans for long periods. Animal studies and short human trials tell you about acute effects. They don't tell you what happens to a 40-year-old who takes BPC-157 cycles for a decade. Nobody knows. Anyone claiming to know is selling something.
Specific red flags by compound. Some peptides have real, named risks. Melanotan II has been associated with new or changing moles and melanoma concerns. Dihexa targets a pathway (HGF/c-Met) that's also involved in tumor growth, which is why people with any cancer history should stay away. Growth hormone secretagogues can affect blood sugar. Each compound page on Kalios lays out the specific risks for that specific peptide — this section is just to say: they exist, and they're compound-specific, and you should read them.
Interactions. Peptides can interact with prescription medications, other peptides, and various supplements. Most of these interactions are poorly studied. If you're on any prescription medication, a conversation with your doctor before adding anything is the right move — even if the conversation is awkward.
What to do next
If you're still curious after reading all that, here's a realistic order of operations:
- Start with a compound that actually has human data. FDA-approved peptides have been through actual trials. If weight loss is the goal, semaglutide or tirzepatide have more evidence behind them than any research peptide. If you want the established-but-boring answer, that's it.
- Talk to a doctor. Preferably one who isn't freaked out by the topic. Telehealth clinics that specialize in hormone and peptide therapy exist precisely because most primary care doctors don't follow this space. They're not perfect, but they're a supervised legal path.
- If you're going the research-chemical route anyway, treat it like the experiment it is. Start with one compound, not a stack. Use low doses first. Buy from vendors who provide recent third-party testing. Keep a log. Get bloodwork before and after. Know the specific risks for your specific compound.
- Read the compound pages on Kalios for anything you're considering. Every page tries to answer: what does it do, does the evidence hold up, how do people use it, what can go wrong, and what does it cost. That's the rest of this site.
Kalios is a reference, not a recommendation. We take no position on whether you should use any peptide. The goal is just to make sure that whatever you decide, you're deciding with the best information we can honestly give you.